Stem Cell Systems

Stem Cell Systems is a Japanese biotechnology company specializing in the infrastructure and commercialization of regenerative medicine. As a subsidiary of the publicly traded StemCell Institute, the company provides comprehensive services including the management of Cell Processing Centers (CPC), consulting for regenerative medicine clinical trials, and the development of specialized cell culture media. Stem Cell Systems plays a critical role in the Japanese regenerative medicine ecosystem by bridging the gap between academic research and clinical application, particularly in the areas of cord blood and mesenchymal stem cell processing. Their business model encompasses both service-oriented consulting and the manufacturing of essential reagents for cell therapy production.